ATLANTA, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of ...
SAN ANTONIO, Texas, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and ...
The updated definition will be published as a report in the society’s journal Fertility and Sterility in about a week or 10 days, Sean Tipton, ASRM’s chief advocacy and policy officer, said Monday. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback